search
Back to results

Long Non Coding RNA in Complications of Systemic Lupus

Primary Purpose

Complication in Systemic Lupus Erythematosus

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
blood sampling
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Complication in Systemic Lupus Erythematosus

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • with systemic lupus

Exclusion Criteria:

vasculitis

Sites / Locations

  • Cairo UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

SLE group

control group

Arm Description

Outcomes

Primary Outcome Measures

non coding RNA expression by real time PCR
non coding RNA expression by real time PCR to evaluate thier role in lupus

Secondary Outcome Measures

Full Information

First Posted
June 3, 2017
Last Updated
June 11, 2017
Sponsor
Cairo University
search

1. Study Identification

Unique Protocol Identification Number
NCT03185767
Brief Title
Long Non Coding RNA in Complications of Systemic Lupus
Official Title
Long Non Coding RNA IN Systemic Lupus
Study Type
Interventional

2. Study Status

Record Verification Date
June 2017
Overall Recruitment Status
Unknown status
Study Start Date
June 1, 2016 (Actual)
Primary Completion Date
June 30, 2017 (Anticipated)
Study Completion Date
July 1, 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
the precise role of RNA in setting of this complication in systemic lupus erythematosus (SLE) is largely unknown

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Complication in Systemic Lupus Erythematosus

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
SLE group
Arm Type
Other
Arm Title
control group
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
blood sampling
Intervention Description
blood sampling
Primary Outcome Measure Information:
Title
non coding RNA expression by real time PCR
Description
non coding RNA expression by real time PCR to evaluate thier role in lupus
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: with systemic lupus Exclusion Criteria: vasculitis
Facility Information:
Facility Name
Cairo University
City
Cairo
ZIP/Postal Code
202
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
mai ahmed, master
Phone
01066625682
Email
dr_mei_ahmed_87@yahoo.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Long Non Coding RNA in Complications of Systemic Lupus

We'll reach out to this number within 24 hrs